You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 52 No. 9, September 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical Validity of the Mattis Dementia Rating Scale in Detecting Dementia of the Alzheimer Type

A Double Cross-Validation and Application to a Community-Dwelling Sample

Andreas U. Monsch, PhD; Mark W. Bondi, PhD; David P. Salmon, PhD; Nelson Butters, PhD; Leon J. Thal, MD; Lawrence A. Hansen, MD; Wigbert C. Wiederholt, MD; Deborah A. Cahn, PhD; Melville R. Klauber, PhD

Arch Neurol. 1995;52(9):899-904.


Abstract

Objective
To assess the clinical validity of the Dementia Rating Scale (DRS) in detecting patients with dementia of the Alzheimer type (DAT).

Background
The DRS is widely used to evaluate cognitive functioning in older adults. Adequate normative data are unavailable; studies addressing the clinical validity of the DRS are limited by small sample sizes.

Design and Methods
Administered the DRS to 254 outpatients with DAT and 105 healthy elderly subjects. Performed (1) multiple regressions of demographic factors on the DRS and its subscales; (2) derivation of optimal DRS cutoff scores using receiver operating characteristic curves; (3) double cross-validation with stepwise logistic regressions; and (4) application of results to a community-dwelling sample.

Results
Age- and education-adjusted DRS scores were computed. The optimal DRS cutoff score for DAT of 129 or less revealed a sensitivity of 98% and a specificity of 97%. The logistic regressions resulted in a combination of the Memory and Initiation/Perseveration subscales that correctly classified 98% of all subjects, 92% of a subsample of 76 patients with mild DAT, and 100% of the 51 patients with autopsyconfirmed DAT. The resultant equation was then applied to a community-dwelling sample (238 healthy elderly subjects and 44 patients with DAT): 91% of patients and 93% of normal subjects were correctly classified. Of an additional 77 individuals with questionable DAT, 43 were classified as demented and 34 were classified as nondemented.

Conclusions
The DRS is a clinically valid psychometric test for the detection of DAT. The Memory and Initiation/Perseveration subscales are its best discriminative indexes for an abbreviated version.



Author Affiliations

From the Departments of Psychiatry (Drs Monsch, Bondi, Butters, and Cahn), Neurosciences (Drs Salmon, Thal, Hansen, and Wiederholt), and Family and Preventive Medicine (Dr Klauber), University of California, San Diego, School of Medicine, and the San Diego Department of Veterans Affairs Medical Center (Drs Bondi, Butters, Thal, and Cahn). Dr Monsch is now with the Memory Clinic of the Geriatric University Hospital, Basel, Switzerland.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Efficacy of a Vitamin/Nutriceutical Formulation for Moderate-stage to Later-stage Alzheimer's disease: A Placebo-controlled Pilot Study
Remington et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2009;24:27-33.
ABSTRACT  

Efficacy of a Vitamin/Nutriceutical Formulation for Early-stage Alzheimer's Disease: A 1-year, Open-label Pilot Study With an 16-Month Caregiver Extension
Chan et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2009;23:571-585.
ABSTRACT  

Percutaneous Vertebroplasty for Painful Compression Fractures in a Small Cohort of Patients with a Decreased Expectation-Related Placebo Effect due to Dementia
Lehman et al.
Am. J. Neuroradiol. 2008;29:1461-1464.
ABSTRACT | FULL TEXT  

Perspectives on Depression, Mild Cognitive Impairment, and Cognitive Decline
Steffens et al.
Arch Gen Psychiatry 2006;63:130-138.
ABSTRACT | FULL TEXT  

Screening of Dementia in Stroke Patients With Lacunar Infarcts: Comparison of the Mattis Dementia Rating Scale and the Mini-Mental State Examination
Tang et al.
J Geriatr Psychiatry Neurol 2005;18:3-7.
ABSTRACT  

Treatable Comorbid Conditions and Use of VA Health Care Services Among Patients With Dementia
Kunik et al.
Psychiatr. Serv. 2005;56:70-75.
ABSTRACT | FULL TEXT  

The Clock Drawing Test as a Measure of Executive Dysfunction in Elderly Depressed Patients
Woo et al.
J Geriatr Psychiatry Neurol 2004;17:190-194.
ABSTRACT  

Impaired financial abilities in mild cognitive impairment: A direct assessment approach
Griffith et al.
Neurology 2003;60:449-457.
ABSTRACT | FULL TEXT  

Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals
Salmon et al.
Neurology 2002;59:1022-1028.
ABSTRACT | FULL TEXT  

The Global Deterioration Scale: Relationships to Neuropsychological Performance and Activities of Daily Living in Patients with Vascular Dementia
Paul et al.
J Geriatr Psychiatry Neurol 2002;15:50-54.
ABSTRACT  

The Effects of Age, Education, and Gender on the Mattis Dementia Rating Scale Performance of Elderly Chinese and American Individuals
Chan et al.
Journals of Gerontology Series B: Psychological Sciences and Social Science 2001;56:P356-363.
ABSTRACT | FULL TEXT  

Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
Petersen et al.
Neurology 2001;56:1133-1142.
ABSTRACT | FULL TEXT  

Validity of the Dementia Rating Scale in Assessing Cognitive Function in Parkinson's Disease
Brown et al.
J Geriatr Psychiatry Neurol 1999;12:180-188.
ABSTRACT  

Cognitive Deficits and Psychopathology in Institutionalized versus Community-Dwelling Elderly Schizophrenia Patients
Evans et al.
J Geriatr Psychiatry Neurol 1999;12:11-15.
ABSTRACT  

Selective Cortical and Hippocampal Volume Correlates of Mattis Dementia Rating Scale in Alzheimer Disease
Fama et al.
Arch Neurol 1997;54:719-728.
ABSTRACT  

Neuropsychological Assessment of Severely Demented Elderly: The Severe Cognitive Impairment Profile
Peavy et al.
Arch Neurol 1996;53:367-372.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.